Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
SAR QSAR Environ Res ; 25(8): 637-49, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25027467

RESUMO

There has been considerable interest in DNA topoisomerases over the last decade, as they have been shown to be one of the major cellular targets in anticancer drug development. Previously we synthesized some benzothiazole derivatives and corresponding benzothiazolium forms, and tested their DNA inhibitory activity to develop novel antitumor agents. Among the 12 prepared compounds, compound BM3 (3-aminobenzothiazole-3-ium 4-methylbenzene sulfonate) exhibited extreme topoisomerase II inhibitory activity compared with the reference drug etoposide. We also tried to determine the DNA and enzyme binding abilities of BM3 and found that BM3 acted on topoisomerase II first at low doses, while it had also showed DNA minor groove binding properties at higher doses. In this study the interactions between DNA topoisomerase II and the compounds were examined in detail by molecular modelling studies such as molecular docking and pharmacophore analysis performed using Discovery Studio 3.5. As a result, it was found that benzothiazolium compounds exhibited a totally different mechanism than benzothiazoles by binding to the different amino acids at the active site of the protein molecule. 3-Aminobenzothiazoliums are worthy of carrying onto anticancer studies; BM3 especially would be a good anticancer candidate for preclinical studies.


Assuntos
Benzotiazóis/farmacologia , Modelos Moleculares , Relação Quantitativa Estrutura-Atividade , Inibidores da Topoisomerase II , Antineoplásicos/química , Benzotiazóis/química , DNA Topoisomerases Tipo II/metabolismo , Desenho de Fármacos , Simulação de Acoplamento Molecular , Neoplasias/tratamento farmacológico
2.
Phys Rev Lett ; 110(4): 042502, 2013 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-25166157

RESUMO

Heavy nuclei exhibit a crossover from vibrational to rotational collectivity as the number of neutrons or protons increases from shell closure towards midshell, but the microscopic description of this crossover has been a major challenge. We apply the shell model Monte Carlo approach to families of even-even samarium and neodymium isotopes and identify a microscopic signature of the crossover from vibrational to rotational collectivity in the low-temperature behavior of ⟨J(2)⟩(T), where J is the total spin and T is the temperature. This signature agrees well with its values extracted from experimental data. We also calculate the state densities of these nuclei and find them to be in very good agreement with experimental data. Finally, we define a collective enhancement factor from the ratio of the total state density to the intrinsic state density as calculated in the finite-temperature Hartree-Fock-Bogoliubov approximation. The decay of this enhancement factor with excitation energy is found to correlate with the pairing and shape phase transitions in these nuclei.

3.
Eur J Clin Pharmacol ; 68(5): 543-51, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22116461

RESUMO

BACKGROUND: The interest in adaptive study design is evident from the growing amount of clinical research employing this model in the mid to later stages of medicines development. Little has been published on the practical application and merits of adaptive study design in early phase clinical research. METHODS: This paper describes a retrospective analysis performed on a sample of 29 industry lead adaptive early phase studies commencing between 1 January 2006 and 31 December 2010 in a clinical trials unit in London, England. All studies containing at least one adaptive feature in the original protocol were included in the analysis. The scope of the analysis was to assess whether the use of adaptive study designs provided tangible benefits over the use of conventional study designs using time savings as the main measure. CONCLUSION: We conclude that the use of adaptive study design saves time in early phase research programs. This is achieved by abolishing the need for substantial amendments or by mitigating their impact on timelines and by using adaptive scheduling efficiencies.


Assuntos
Ensaios Clínicos Fase I como Assunto , Drogas em Investigação/efeitos adversos , Projetos de Pesquisa , Ensaios Clínicos Fase I como Assunto/economia , Redução de Custos , Tomada de Decisões Gerenciais , Drogas em Investigação/administração & dosagem , Drogas em Investigação/farmacologia , Drogas em Investigação/uso terapêutico , Humanos , Londres , Avaliação de Programas e Projetos de Saúde , Estudos Retrospectivos , Fatores de Tempo
4.
Vet Immunol Immunopathol ; 141(3-4): 201-8, 2011 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-21477869

RESUMO

Streptococcus uberis is an important environmental mastitis pathogen that causes subclinical and clinical mastitis in lactating and nonlactating cows and heifers throughout the world. Previous work from our laboratory suggests that S. uberis adhesion molecule (SUAM) is involved in S. uberis pathogenesis and may be an excellent target for vaccine development. The objective of this study was to evaluate the antibody response of cattle vaccinated with recombinant SUAM (rSUAM). Uninfected primiparous dairy cows (n=30) in late lactation were divided randomly into three groups of 10 cows each: control, 200 µg rSUAM, and 400 µg rSUAM. Cows in groups vaccinated with 200 µg and 400 µg rSUAM received an emulsion containing adjuvant, phosphate-buffered saline (PBS) and affinity purified rSUAM. Cows in the control group received an emulsion containing adjuvant and PBS. Cows were vaccinated subcutaneously in the neck region at drying off (D-0), 28 d after drying off (D+28) and within 7 d after calving. Serum was collected at D-0, D+28, at calving (C-0), calving vaccination (CV), and during early lactation (CV+14). Serum antibody responses were measured by an ELISA against rSUAM. Following the first vaccination a significant increase in anti-rSUAM antibodies was detected at D+28 in cows from groups vaccinated with 200 µg and 400 µg rSUAM when compared to the control group. This increase in anti-rSUAM antibodies continued following the second immunization at D+28; reaching the highest levels in the post-parturient sampling period (C0), after which antibodies appeared to plateau. S. uberis UT888 pretreated with several dilutions of heat-inactivated serum from cows vaccinated with rSUAM, affinity purified antibodies against rSUAM, and to a 17 amino acid long peptide from the N terminus of SUAM (pep-SUAM) were co-cultured with bovine mammary epithelial cells and adherence to and internalization of S. uberis into epithelial cells was measured. Compared to untreated controls, opsonization of two strains of S. uberis with sera from cows vaccinated with rSUAM, with affinity purified rSUAM antibodies, or with affinity purified pep-SUAM antibodies significantly reduced adherence to and internalization of this pathogen into bovine mammary epithelial cells. In conclusion, subcutaneous vaccination of dairy cows with rSUAM during physiological transitions of the mammary gland either from or to a state of active milk synthesis induced antibodies in serum and milk and these antibodies reduced adherence to and internalization of S. uberis into mammary epithelial cells under in vitro conditions. SUAM appears to be an excellent candidate for vaccine development.


Assuntos
Vacinas Bacterianas/imunologia , Moléculas de Adesão Celular/imunologia , Células Epiteliais/microbiologia , Mastite Bovina/prevenção & controle , Streptococcus/fisiologia , Animais , Anticorpos Antibacterianos/análise , Aderência Bacteriana/imunologia , Aderência Bacteriana/fisiologia , Proteínas de Bactérias/química , Proteínas de Bactérias/imunologia , Proteínas de Bactérias/metabolismo , Bovinos , Colostro/química , Indústria de Laticínios , Feminino , Glândulas Mamárias Animais/citologia , Mastite Bovina/microbiologia , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/metabolismo , Soro , Streptococcus/imunologia , Vacinas Sintéticas/imunologia
6.
Phys Rev Lett ; 99(20): 202502, 2007 Nov 16.
Artigo em Inglês | MEDLINE | ID: mdl-18233137

RESUMO

Level densities of J pi=2+ and 2- states extracted from high-resolution studies of E2 and M2 giant resonances in 58Ni and 90Zr are used to test recent predictions of a possible parity dependence. The experimental results are compared to a combinatorial approach based on the Hartree-Fock-Bogoliubov model and to shell-model Monte Carlo calculations including both spin and parity projection. No parity dependence is observed experimentally, which is in agreement for 90Zr but in contrast with the model predictions for 58Ni.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...